Welcome to The Systemic Mastocytosis Channel
Discover need-to-know updates with exclusive interviews from globally renowned experts, brought to you by VJHemOnc. Systemic mastocytosis, a rare group of mast cell neoplasms with variable symptomatology and prognosis, has limited treatment options and a substantial research focus is dedicated to the development of novel targeted potential therapies. VJHemOnc shares important updates from international congresses as advancements in precision medicine techniques drive progress in this field.
Explore The Systemic Mastocytosis Channel to find key data from major clinical trials, as well as the latest investigations into diagnostic and prognostic biomarkers, molecular genetics, and clinical care.
